Somerville Welcomes New Life Sciences Complex to Assembly Square

BioMed Realty, a leading provider of real estate solutions to the life science and technology industries, has announced the acquisition of an existing 162,000 square foot office building and adjacent 7.5 acre site at Assembly Square in Somerville. The Assembly Square campus will be developed in phases and represents a total of 1.3 million square feet of best-in-class, purpose-built innovation space for research, technology, and life science tenants.

The Assembly Square location is a strategic addition to BioMed Realty’s established portfolio of lab and office space in nearby Cambridge and Boston’s Longwood Medical Area and Seaport District. The Assembly Square site further strengths BioMed Realty’s leadership position as an owner and operator of one of the largest life science real estate portfolios in the area. In close proximity to MIT, Harvard and other top tier research and education institutions, Assembly Square provides convenient access to world-leading scientific research, established biotech companies and capital providers within the region’s life science ecosystem.

“We are excited to welcome BioMed Realty as a new innovator in the Assembly Square tech ecosystem,” said Somerville Mayor Joe Curtatone. “Having a world-leading life science developer launch this new major life science cluster in Somerville will open up the growth, jobs and new opportunities our community seeks. Simply put, it opens the door for our city to become a pioneer in the biotechnology space. Assembly Square will become a place where life science professionals collaborate, experiment, discover and advance the nation’s – and world’s – efforts to tackle vital health challenges.” (Source: BioMed Realty Website, 19 January, 2021)